BBP: An Outperforming Biotechnology ETF
July 21, 2016 at 15:53 PM EDT
The BioShares Biotechnology Products Fund (NasdaqGM: BBP) has capitalized on a string of acquisitions and outperformed other biotechnology- and pharmaceuticals-related exchange traded funds. BBP, which follows U.S.-listed biotech companies with a primary product offering or product candidate that...